Company Overview of GlaxoSmithKline LLC
GlaxoSmithKline LLC focuses on discovering, developing, and delivering medicines, vaccines, and other healthcare products for customers in the United States. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. The company also provides vaccines for children and adults; and over-the-counter products. GlaxoSmithKline LLC was formerly known as SmithKline Beecham Corporation. The company was incorporated in 1929 and is based in Philadelphia, Pennsylvania. GlaxoSmithKline LLC operates as a subsidiary of GlaxoSmith...
5 Crescent Drive
Philadelphia, PA 19112
Founded in 1929
Key Executives for GlaxoSmithKline LLC
Compensation as of Fiscal Year 2015.
GlaxoSmithKline LLC Key Developments
Lieff Cabraser Heimann & Bernstein, LLP Files Personal Injury Lawsuit on GlaxoSmithkline LLC
Nov 6 15
Sarah R. London and Paulina do Amaral of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that Robin and Stanley Zgurski, residents of Florida, have filed a personal injury lawsuit against GlaxoSmithKline LLC (GSK) for the injuries suffered by their son allegedly as a result of Ms. Zgurski being prescribed GSK's drug ondansetron brand name Zofran while pregnant. Zofran is a potent drug developed by GSK that was approved by the U.S. Food and Drug Administration to treat only patients afflicted with the most severe nausea imaginable - nausea suffered as a result of chemotherapy or radiation treatment. GSK nevertheless marketed Zofran "off-label" as a safe and effective treatment for the very common side effect of a normal pregnancy - pregnancy-related nausea and vomiting - otherwise known as "morning sickness." In 2012, GSK pled guilty to criminal charges filed by the U.S. Department of Justice for its off-label promotion of certain prescription drugs, including Zofran, for uses never approved by the FDA. Zofran, however, continues to be widely prescribed to pregnant women across America to treat morning sickness even though it was never approved for this use. The Zgurskis’ son was born in 2006 with a bilateral cleft lip and palate and has been through multiple surgeries and countless visits with various physicians and specialists, receiving care in three different states thus far. He underwent his first medical intervention within his first few weeks of life and had his first surgery before he was even one year old. He has had and continues to have difficulty eating, speaking, and hearing. His birth defects have impaired his development in a variety of ways and interfered with his enjoyment of life both at home and at school. The lawsuit was filed Friday November 6th in federal court in San Francisco. The lawsuit alleges claims of negligence, strict products liability, intentional misrepresentation, concealment, negligent misrepresentation, breach warranty, and violations of California law. The Zgurskis seek compensatory and punitive damages from GSK.
Katherine and Matthew Murray Files Personal Injury Lawsuit Against GlaxosmithKline LLC
Oct 1 15
Lieff Cabraser Heimann & Bernstein, LLP, announced that Katherine and Matthew Murray, residents of Alameda County, California, have filed a personal injury lawsuit against GlaxoSmithKline LLC (GSK) for the injuries suffered by their daughter allegedly as a result of Ms. Murray being prescribed while pregnant GSK's drug ondansetron, sold under the brand name Zofran. Zofran is a powerful drug developed by GSK and approved by the U.S. Food and Drug Administration to treat only those patients who were afflicted with the most severe nausea imaginable "nausea suffered as a result of chemotherapy or radiation treatments in cancer patients. GSK marketed Zofran off-label as a safe and effective treatment for the very common side effect of a normal pregnancy "pregnancy-related nausea and vomiting " otherwise known as morning sickness. The Murray’s daughter was born in 2007 with severe congenital heart malformations and had to undergo numerous examinations culminating in surgery at age four. The complaint alleges that none of the injuries the Murray’s daughter suffered would have occurred if GlaxoSmithKline had not concealed the risks of taking Zofran during pregnancy. Despite having received hundreds of reports of birth defects associated with Zofran and continuing strong sales to pregnant women, GSK has not performed any clinical studies on the safety or efficacy of Zofran for treating morning sickness, stated London, counsel for the Murrays. Moreover, GSK has not updated Zofran’s labeling to warn mothers and physicians that epidemiology studies report an increased risk of birth defects in infants exposed to Zofran during pregnancy. Recent studies report that a mother exposed to Zofran had more than a doubled risk of having a baby with a congenital heart defect as compared to a mother who did not ingest Zofran during pregnancy. The lawsuit was filed Tuesday in federal court in San Francisco. he lawsuit alleges claims of negligence, misrepresentation, concealment, breach of warranty, and violations of California law. The Murrays seek compensatory and punitive damages from GSK.
GlaxoSmithKline LLC Wins $13 Million Federal Contract
Dec 30 14
GlaxoSmithKline LLC won a $13,000,127 federal contract from the U.S. Department of Health and Human Services' Office of the Secretary for the advanced research and development of chemical, biological, radiological and nuclear medical countermeasures for the Biomedical Advanced Research and Development Authority.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|